SPP1 and chronic obstructive pulmonary disease: The expression level of SPP1 in the COPD group was significantly higher compared with either non‐smokers (P = 0.002) or smokers (P = 0.001), and the level was further up‐regulated with an enormous increase in the group of NSCLC coexisting with COPD (P < 0.001).